Comments

Akero Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Akero Therapeutics (AKRO) operate in?

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

AKRONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$55.62

2.063.85%

At close: -

$54.65

-0.97-1.74%

After Hours: Jun 13, 7:12 PM EDT

Akero Therapeutics (AKRO) Forecast

News Earnings Akero Therapeutics (AKRO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Akero Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AKRO | Benzinga

Explore Akero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AKRO.

Open	$52.19
Close	$55.62
Volume / Avg.	2.22M / 1.47M
Day Range	$52.19 - $55.83
52 Wk Range	21.02 - 58.40
Market Cap	$4.36B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	8.92%
Days to Cover	2.76

Recent News

Best Biotech Stocks to Buy in 2025

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market in 2023 and 2024,

MarketBeat

3 Mid-Caps Worth Watching Closely in March

Mid-cap stocks don’t get the same headlines as large caps but move aggressively in both directions, creating outsized opportunities for investors. Unlike their mega-cap counterparts, which tend to grind higher or

MarketBeat

Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?

Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$52.19
Close	$55.62
Volume / Avg.	2.22M / 1.47M
Day Range	$52.19 - $55.83
52 Wk Range	21.02 - 58.40
Market Cap	$4.36B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	8.92%
Days to Cover	2.76

About Akero Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercia...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Akero Therapeutics (AKRO) stock?

You can purchase shares of Akero Therapeutics (NASDAQ:AKRO) through any online brokerage.

View our list of the best stock brokerages

Who are Akero Therapeutics (AKRO) competitors?

Other companies in Akero Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Akero Therapeutics (AKRO) stock?

Akero Therapeutics has a consensus price target of $68.22.

What is the current price for Akero Therapeutics (AKRO)?

The stock price for Akero Therapeutics (NASDAQ: AKRO) is $54.6501 last updated June 13, 2025 at 7:12 PM EDT.

Does Akero Therapeutics (AKRO) pay a dividend?

There are no upcoming dividends for Akero Therapeutics.

When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?

Akero Therapeutics’s Q2 earnings are confirmed for Friday, August 8, 2025.

Is Akero Therapeutics (AKRO) going to split?

There is no upcoming split for Akero Therapeutics.

What sector and industry does Akero Therapeutics (AKRO) operate in?

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.